- Teladoc was a big stock market winner during the pandemic as medicine went virtual. However, the reopening and concerns about valuation and growth potential have pressured shares, down roughly 50% from its peak this year.
- It does not help that Amazon has set its sights on the health-care industry.
- Teladoc CEO Jason Gorevic isn t worried about Amazon, saying the threat is overrated, but Wall Street analysts say there are questions about the company s ability to grow into new care categories, along with better earnings and margins.
